Skip to main content
Premium Trial:

Request an Annual Quote

MDS Sciex Revenues Slip 4 Percent in Fiscal Q1 as Earnings Slide

NEW YORK, March 9 (GenomeWeb News) - MDS today reported that instrument sales during its fiscal first quarter declined 4 percent to $71 million from $74 million for the year-ago period.

 

Profits for MDS Sciex also fell to $19 million from $21 million in the first quarter of 2005, a 9.5-percent decline. The company said the decrease was "principally due to currency."

 

MDS said that the best-selling products in its Sciex unit were the API 5000, the 4800 MALDI/Tof/TOF, and the 3200 Qtrap. MDS Sciex shipped the first CellKey system produced at the new Singapore facility in the quarter.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.